We are an R&D driven and oriented biopharmaceutical company, and have built an integrated and efficient global R&D platform with key facilities in Shanghai, Taipei and California closely collaborating with each other to ensure the highly productive and cost-efficient R&D processes.
Shanghai R&D Center
Shanghai Center is mainly in charge of R&D in later stages, such as process and formulation development, and enables us to leverage the abundance of high-calibre talent in Shanghai as well as its proximity to the Xuhui Facility, where we intend to manufacture our approved products on a commercial scale.
Taipei R&D Center
Taipei Center is mainly responsible for early-stage R&D with focus on candidate screening, new drug clinical registration and trial, and improving the efficacy of pre-clinical candidates via In Vitro and In Vivo analysis.
California R&D Center
California Center provides us with quick access to the latest developments in the mAb field and cutting-edge technologies, mainly responsible for early-stage R&D with a focus on cell line construction and screening.